Full Press Release Details
Insulet Announces Organizational Changes
Focus on Operational Excellence
BILLERICA, MA- June 30, 2015 - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, today announced a series of organizational changes designed to continue its focus on improving operational performance and to drive faster communication and greater integration between departments.
Mr. Licari and Mr. Colleran will report directly to Patrick Sullivan, President and Chief Executive Officer.
"On behalf of the Insulet Board and management team, I would like to thank Tony and Patrick for their respective contributions to Insulet and wish them both well in their future endeavors," said Patrick Sullivan, President and Chief Executive Officer. "Looking forward, we are excited to leverage the new leadership team's extensive experience and long track records of individual career success."
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and a fully-automated cannula insertion. Insulet's subsidiary, Neighborhood Diabetes, is a leading distributor of diabetes products and supplies, delivered through a high touch customer service model. To read inspiring stories of people with diabetes living their lives to the fullest with OmniPod, visit our customer blog, Suite D: http://suited.myomnipod.com. Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts. For more information, please visit: http://www.myomnipod.com.
Investor Relations and Media Contact:
Vice President, Investor Relations and Corporate Communications